Atlas Trials

Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder

Clinical trial NCT01168674 · COMPLETED

Trial details

NCT number
NCT01168674
Sponsor
Tufts Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DepressionBipolar Disorder
Start date
2010-02-01
Primary completion
2011-12-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.